Skip to main content
Top
Published in: Dermatology and Therapy 4/2021

Open Access 01-08-2021 | Atopic Dermatitis | Original Research

A Qualitative Analysis of Provider Notes of Atopic Dermatitis-Related Visits Using Natural Language Processing Methods

Authors: Evangeline J. Pierce, Natalie N. Boytsov, Joe J. Vasey, Theresa C. Sudaria, Xiong Liu, Kevin W. Lavelle, Alina N. Bogdanov, Orin M. Goldblum

Published in: Dermatology and Therapy | Issue 4/2021

Login to get access

Abstract

Introduction

Real-world disease management of atopic dermatitis (AD) is hampered by a lack of consistency between providers that treat AD regarding assessment of severity, disease activity, and quality of life. Variability and inconsistency in documentation makes it difficult to understand the impact of AD. This study summarizes AD-related symptoms and concerns captured in unstructured qualitative provider notes by healthcare providers during visits with patients with AD.

Methods

Provider notes were obtained for patients with AD (n = 133,025) from a USA-based ambulatory electronic health records system. The sample included both children (n = 69,551) and adults at least 18 years of age (n = 63,474) receiving treatment from a variety of specialties including primary care, dermatology, and allergy/immunology. Key skin-related words were identified from a review of a sample of notes and natural language processing (NLP) was applied to determine the frequency of the keywords and bigram patterns.

Results

Provider notes largely focused on symptoms (primarily itch) and symptom relief rather than the impact of AD on work or lifestyle. Despite the known relationship between itch and skin pain, neuralgia was not widely documented. Compared to primary care providers, dermatologists’ and allergist/immunologists’ notes had more documentation of symptom-related issues. Personal and work/life burden issues were not widely documented regardless of specialty.

Conclusion

The topics documented in case notes by healthcare providers about their patients with AD focus largely on symptoms and, to a lesser extent, treatment, but do not reflect the burden of AD on patients’ lives. This finding highlights a potential care gap that warrants further investigation.
Literature
2.
go back to reference Berke S, Singh A, Guralnick M. Atopic dermatitis: an overview. Am Fam Physician. 2012;86(1):35–42.PubMed Berke S, Singh A, Guralnick M. Atopic dermatitis: an overview. Am Fam Physician. 2012;86(1):35–42.PubMed
3.
go back to reference Silverberg J. Public health burden and epidemiology of atopic dermatitis. Dermatol Clin. 2017;35(3):283–9.CrossRef Silverberg J. Public health burden and epidemiology of atopic dermatitis. Dermatol Clin. 2017;35(3):283–9.CrossRef
4.
go back to reference Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract. 2006;60(8):984–92.CrossRef Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract. 2006;60(8):984–92.CrossRef
5.
go back to reference Lifschitz C. The impact of atopic dermatitis on quality of life. Ann Nutr Metab. 2005;66:34–40.CrossRef Lifschitz C. The impact of atopic dermatitis on quality of life. Ann Nutr Metab. 2005;66:34–40.CrossRef
9.
go back to reference Nakamura T, Haider S, Colicino S, et al. Different definitions of atopic dermatitis: impact on prevalence estimates and associated risk factors. Br J Dermatol. 2019;181:1272–9.CrossRef Nakamura T, Haider S, Colicino S, et al. Different definitions of atopic dermatitis: impact on prevalence estimates and associated risk factors. Br J Dermatol. 2019;181:1272–9.CrossRef
10.
go back to reference Schmitt J, Apfelbacher C, Spuls P. The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framewaork to develop core sets of outcome measurements in dermatology. J Invest Dermatol. 2015;135:24–30.CrossRef Schmitt J, Apfelbacher C, Spuls P. The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framewaork to develop core sets of outcome measurements in dermatology. J Invest Dermatol. 2015;135:24–30.CrossRef
15.
go back to reference Correale C, Walker C, Murphy L, Craig T. Atopic dermatitis: a review of diagnosis and treatment. Am Fam Physician. 1999;60(4):1191–8.PubMed Correale C, Walker C, Murphy L, Craig T. Atopic dermatitis: a review of diagnosis and treatment. Am Fam Physician. 1999;60(4):1191–8.PubMed
16.
go back to reference Silverberg J, Gelfand J, Margolis D, Fuxench Z, Simpson E, Ong P. Pain is a common and burdensome symptom of atopic dermatitis in United States adults. J Allergy Clin Immunol. 2019;7(8):2699–706.CrossRef Silverberg J, Gelfand J, Margolis D, Fuxench Z, Simpson E, Ong P. Pain is a common and burdensome symptom of atopic dermatitis in United States adults. J Allergy Clin Immunol. 2019;7(8):2699–706.CrossRef
17.
go back to reference Vakharia P, Chopra R, Sacotte R, et al. Burden of skin pain in atopic dermatitis. Ann Allergy Asthma Immunol. 2018;119(6):548–52.CrossRef Vakharia P, Chopra R, Sacotte R, et al. Burden of skin pain in atopic dermatitis. Ann Allergy Asthma Immunol. 2018;119(6):548–52.CrossRef
18.
go back to reference Chang Y, Chiang B. Sleep disorders and atopic dermatitis: a 2-way street? J Allergy Clin Immunol. 2018;142:1033–40.CrossRef Chang Y, Chiang B. Sleep disorders and atopic dermatitis: a 2-way street? J Allergy Clin Immunol. 2018;142:1033–40.CrossRef
19.
go back to reference Hon K, Leung T, Wong K, Chow C, Chuh A, Ng P. Does age or gender influence quality of life in children with atopic dermatitis? Clin Exp Dermatol. 2008;33:705–9.CrossRef Hon K, Leung T, Wong K, Chow C, Chuh A, Ng P. Does age or gender influence quality of life in children with atopic dermatitis? Clin Exp Dermatol. 2008;33:705–9.CrossRef
21.
go back to reference Kiebert G, Sorensen S, Revicki D, et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol. 2002;41(3):151–8.CrossRef Kiebert G, Sorensen S, Revicki D, et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol. 2002;41(3):151–8.CrossRef
22.
go back to reference Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol. 2000;80:430–4.CrossRef Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol. 2000;80:430–4.CrossRef
23.
go back to reference Chernyshov P. Gender differences in health-related and family quality of life in young children with atopic dermatitis. Int J Dermatol. 2012;51(3):290–4.CrossRef Chernyshov P. Gender differences in health-related and family quality of life in young children with atopic dermatitis. Int J Dermatol. 2012;51(3):290–4.CrossRef
24.
go back to reference Chopra R, Silverberg J. Assessing the severity of atopic dermatitis in clinical trials. Clin Dermatol. 2018;36(5):606–15.CrossRef Chopra R, Silverberg J. Assessing the severity of atopic dermatitis in clinical trials. Clin Dermatol. 2018;36(5):606–15.CrossRef
Metadata
Title
A Qualitative Analysis of Provider Notes of Atopic Dermatitis-Related Visits Using Natural Language Processing Methods
Authors
Evangeline J. Pierce
Natalie N. Boytsov
Joe J. Vasey
Theresa C. Sudaria
Xiong Liu
Kevin W. Lavelle
Alina N. Bogdanov
Orin M. Goldblum
Publication date
01-08-2021
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 4/2021
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-021-00553-5

Other articles of this Issue 4/2021

Dermatology and Therapy 4/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.